74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Quest Diagnostics Inc
Closed
SectorHealthcare
178.25 0.7
Overview
Share price change
24h
Min
175.48
Max
178.3
Income | 61M 296M |
|---|---|
Sales | 109M 2.8B |
P/E Sector Avg | 20.652 34.393 |
EPS | 2.21 |
Dividend yield | 1.81 |
Profit margin | 10.721 |
Employees | 55,000 |
EBITDA | -37M 451M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +5.71% upside |
Dividend yield Sector Avg | 1.81% 2.54% |
|---|---|
Next Earnings | 21 Oct 2025 |
Next Dividend date | 20 Oct 2025 |
Next Ex Dividend date | 3 Oct 2025 |
Market Cap | 701M 19B |
|---|---|
Previous open | 177.55 |
Previous close | 178.25 |
News Sentiment
By Acuity
28%
72%
65 / 374 Healthcare
Technical Score
By Trading Central
Confidence
Bullish Evidence
Quest Diagnostics Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Quest Diagnostics Inc Forecast
Price Target
By TipRanks
5.71% upside
12 Months Forecast
Average 188.55 USD 5.71%
High 198 USD
Low 178 USD
Based on 12 Wall Street analysts offering 12 month price targets forQuest Diagnostics Inc - Dist in the last 3 months.
Sentiment
By Acuity
65 / 374 Healthcare
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Quest Diagnostics Inc
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
